Visit COVID-19 resources

[Skip to Content]

Document

TREATMENT OF AGE-RELATED MACULAR DEGENERATION BY INTRAVITREAL INJECTION WITH RANIZUMAB (LUCENTIS):Treatment leaflet and Patient Consent form

Dec 31
2014

This leaflet provides information about the eye condition wet age-related macular degeneration (AMD).

  • 31 December 2014

Review of the Ocular side effects of Topiramate

Dec 31
2014

Review of the Ocular side effects of Topiramate by Mr Patrick Watts October 2010

  • 31 December 2014

Ocular side effects of Topiramate: Frequently asked questions

Dec 31
2014

FAQs from the Paediatric Sub-committee October 2010

  • 31 December 2014

Fluocinolone acetonide intravitreal implant for treating chronic DMO after inadequate response to prior therapy

Dec 30
2014

College statement on NICE guidance TA 301 – Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after inadequate response to prior therapy (rapid review of technology appraisal guidance 271) December 2013

  • 30 December 2014

Use of Avastin (bevacizumab) in age related macular degeneration

Dec 30
2014

College statement on the use of Avastin (bevacizumab) in age related macular degeneration December 2014

  • 30 December 2014